This ticker has not been starred yet LPCN Lipocine Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.25
Leverage 12.01%
Market Cap $ 56.9m
PE 0.00
Dividend Yield 0.00%
Profit $ -5.5m
Margin -160.77%

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.

Subscribe Now For Access - Only $1.99 Per Month